NCT05422976View on ClinicalTrials.gov

EVI-01-IT Safety Study

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 23, 2022

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Knee Osteoarthritis
Interventions
DEVICE

EVI-01

High molecular weight Hyaluronic Acid

Trial Locations (1)

40136

IRCCS Istituto Ortopedico Rizzoli, Bologna

Sponsors

Collaborators (1)

Donawa Lifescience
All Listed Sponsors
collaborator

Donawa Lifescience

UNKNOWN

lead

Aptissen SA

INDUSTRY